- Home
- TENX vs HOOK Comparison
TENX vs HOOK Comparison
Compare TENX & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TENX
- HOOK
- Stock Information
- Founded
- TENX 1967
- HOOK 2011
- Country
- TENX United States
- HOOK United States
- Employees
- TENX N/A
- HOOK N/A
- Industry
- TENX Biotechnology: Pharmaceutical Preparations
- HOOK Biotechnology: Pharmaceutical Preparations
- Sector
- TENX Health Care
- HOOK Health Care
- Exchange
- TENX Nasdaq
- HOOK Nasdaq
- Market Cap
- TENX 21.8M
- HOOK 24.5M
- IPO Year
- TENX N/A
- HOOK 2019
- Fundamental
- Price
- TENX $6.37
- HOOK $1.95
- Analyst Decision
- TENX Strong Buy
- HOOK Buy
- Analyst Count
- TENX 4
- HOOK 4
- Target Price
- TENX $20.67
- HOOK $10.67
- AVG Volume (30 Days)
- TENX 38.7K
- HOOK 265.8K
- Earning Date
- TENX 11-13-2024
- HOOK 11-14-2024
- Dividend Yield
- TENX N/A
- HOOK N/A
- EPS Growth
- TENX N/A
- HOOK N/A
- EPS
- TENX N/A
- HOOK N/A
- Revenue
- TENX N/A
- HOOK $49,999,000.00
- Revenue This Year
- TENX N/A
- HOOK $147.52
- Revenue Next Year
- TENX N/A
- HOOK N/A
- P/E Ratio
- TENX N/A
- HOOK N/A
- Revenue Growth
- TENX N/A
- HOOK 143.30
- 52 Week Low
- TENX $2.77
- HOOK $1.72
- 52 Week High
- TENX $21.46
- HOOK $10.50
- Technical
- Relative Strength Index (RSI)
- TENX 57.59
- HOOK 43.79
- Support Level
- TENX $5.92
- HOOK $1.80
- Resistance Level
- TENX $6.65
- HOOK $1.99
- Average True Range (ATR)
- TENX 0.43
- HOOK 0.24
- MACD
- TENX -0.02
- HOOK 0.04
- Stochastic Oscillator
- TENX 56.21
- HOOK 21.66
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.